CURRENT NEWS

• 18.10.2021
  I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination With PD-1 Therapy in China
• 18.10.2021
  Natera Expands Organ Health Business With Commercial Launch of the Prospera Lung Transplant Assessment Test
• 18.10.2021
  Roche Announces Collaboration With Ibex Medical Analytics to Develop Artificial Intelligence-Based Digital Pathology Applications for Improved Patient Care
• 18.10.2021
  'When It is Released, It Will Sell 50 Billion Won at Once'...NewG Lab Pharma, 'Technology
• 17.10.2021
  WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers
• 16.10.2021
  Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence's mRNAi GOLD Platform
• 15.10.2021
  New Glab Pharma, a Green Light for New Drug Development of Taletrectinib… Announcement of Interim Results of Innovent Bio Phase 2 in China
• 15.10.2021
  U.S. FDA Approves Cyltezo (Adalimumab-Adbm) as First Interchangeable Biosimilar With Humira
• 15.10.2021
  Liminal BioSciences Announces Closing of Sale of Remaining Plasma-Derived Therapeutics Business
• 15.10.2021
  Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market
• 15.10.2021
  EVERSANA Acquires Protean; Strengthens Operational Strategy and Excellence in Market Access, Channel and Patient Services
• 15.10.2021
  Seqirus Receives FDA Approval of Its Cell-Based Quadrivalent Influenza Vaccine, Expanding the Age Indication to Include Children as Young as Six Months
• 15.10.2021
  Sensyne Health and OMNY Health Sign Teaming Agreement to Support Breakthrough Research Through the Power of Real World Data and AI
• 15.10.2021
  Chiesi Global Rare Diseases Announces Approval of FERRIPROX (Deferiprone) in Canada for the Treatment of Iron Overload in Sickle Cell Disease
• 15.10.2021
  PathAI Announces Strategic Partnership With Roche to Enable Development and Distribution of Digital Pathology Diagnostics
• 15.10.2021
  Applied BioMath, LLC Announces Collaboration With BYOMass for Systems Pharmacology Modeling in Oncology
• 15.10.2021
  AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI) for the Treatment of Adults With Active Psoriatic Arthritis in the European Union (EU)
• 15.10.2021
  Dong-A ST to Sell Covid-19 Testing Kits for Professionals Overseas
• 15.10.2021
  Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP
• 15.10.2021
  Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia (Ozanimod) as a Treatment for Adult Patients With Moderately to Severely Active Ulcerative Colitis

Records per page:

Page

Total: 21150 records.